Keyphrases
Low-intensity Pulsed Ultrasound (LIPUS)
100%
Focused Ultrasound
91%
Blood-brain Barrier Disruption
74%
Evans Blue
41%
Ultrasound Contrast Agents
35%
Tumor
33%
Ultrasound
31%
Rat Model
28%
Blood-brain Barrier
28%
Pulsed High-intensity Focused Ultrasound
26%
Microbubbles
22%
Transcranial Ultrasound Stimulation
22%
Ordinal Optimization
20%
Brain-derived Neurotrophic Factor
19%
Lipopolysaccharide-induced
18%
Transcranial Focused Ultrasound (tFUS)
18%
Glioma
17%
Glioblastoma multiforme
17%
Ultrasound Treatment
16%
Ultrasound Exposure
16%
Neurotrophic Factors
16%
Brain Injury
16%
Neuroinflammation
16%
Neuroprotective Effect
15%
Good Enough
15%
Good Enough Solution
15%
Functional Change
13%
Solution Space
13%
Computational Efficiency
12%
Traumatic Brain Injury
12%
Protective Effect
12%
Solution Quality
12%
Pegylated Liposomal Doxorubicin
11%
Pharmacokinetic Analysis
11%
Magnetic Resonance Imaging
11%
Specific Peptide
11%
Atherosclerotic Plaque
11%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
11%
Pharmacokinetics
11%
Brain Tumor
10%
Lipopolysaccharide
10%
Pulsed Focused Ultrasound
10%
Peak Systolic Velocity
10%
High-intensity Focused Ultrasound
10%
Quality Efficiency
10%
Booking Limits
9%
Optimization Approach
9%
Antitumor Effect
9%
Mouse Model
9%
Memory Impairment
9%
Pharmacology, Toxicology and Pharmaceutical Science
Blood-Brain Barrier
70%
Neoplasm
45%
Evans Blue
29%
Echo Contrast Medium
25%
Rat Model
25%
Lipopolysaccharide
23%
Mouse
23%
Glioblastoma
19%
Pharmacokinetics
19%
Brain Derived Neurotrophic Factor
17%
Neurotrophic Factor
17%
Neuroprotective Agent
17%
Nervous System Inflammation
16%
Extravasation
15%
Brain Tumor
15%
Inflammation
14%
Traumatic Brain Injury
12%
Doxorubicin
11%
Chemotherapy
11%
Mouse Model
10%
Memory Disorder
9%
Parkinson's Disease
7%
Chitosan
7%
Tumor Growth
7%
Brain Disease
7%
Liposome
7%
Western Blot
7%
Tight Junction Protein
6%
Fluorine 18
6%
Injury
6%
Lipopolysaccharide-Induced Neuroinflammation
6%
Neuroprotection
6%
Malignant Neoplasm
6%
Tumor Model
6%
Contrast Medium
5%
Binding Protein
5%
Oxidopamine
5%
Phosphotransferase
5%
Toll Like Receptor 4
5%
Targeted Drug Delivery
5%
Demyelination
5%
Tropomyosin
5%
Neuroscience
Blood Brain Barrier
85%
Contrast Medium
31%
Brain-Derived Neurotrophic Factor
30%
Neurotrophic Factor
24%
Neuroprotective Agent
24%
Pharmacokinetics
20%
Lipopolysaccharide
19%
Brain Tumor
17%
Brain Injury
13%
Neurotrauma
12%
Traumatic Brain Injury
12%
Protein Expression
12%
In Vivo
12%
Memory Disorder
12%
Doxorubicin
11%
Western Blot
11%
Staining Technique
11%
Magnetic Resonance Imaging
9%
Glioblastoma Multiforme
8%
Astrocyte
8%
Microglia
8%
Hippocampus
8%
Parkinson's Disease
7%
Microdialysis
7%
Fluorine-18
7%
Dementia Praecox
7%
Remyelinization
7%
Multiple Sclerosis
7%
Magnetic Resonance Imaging
7%
Alzheimer's Disease
6%
Neuromodulation
6%
Single-Photon Emission Computed Tomography
6%
Oxidopamine
6%
Neuroprotection
6%
Cyclic Adenosine Monophosphate
5%
Cognitive Disorders
5%
Protein Binding
5%
Response Element
5%
Kinase
5%
TLR 4
5%
Encephalopathy
5%
Prefrontal Cortex
5%
Electrical Brain Stimulation
5%
Substantia Nigra Pars Compacta
5%
Tight Junction Protein
5%
Tropomyosin
5%
Anti-Inflammatory
5%